Genome-Wide Association Analysis-Based Mining of Quality Genes Related to Linoleic and Linolenic Acids in Soybean DOI Creative Commons
Jiabao Wang,

Lu Liu,

Qi Zhang

и другие.

Agriculture, Год журнала: 2023, Номер 13(12), С. 2250 - 2250

Опубликована: Дек. 7, 2023

Soybean fat contains five principal fatty acids, and its acid composition nutritional value depend on the type of soybean oil, storage duration, conditions. Among contents, polyunsaturated such as linoleic linolenic acid, play an essential role in maintaining human life activities; thus, increasing proportions contents can help improve oil. Our laboratory completed SLAF-seq whole genome sequencing natural population (292 varieties) previous growth period. In this study, genome-wide association analysis (GWAS) was performed based genotypic data three-year phenotypic a significant single nucleotide polymorphisms (SNPs) locus (Gm13_10009679) associated with oleic content repeatedly detected over span 3 years using GLM model MLM model. Additionally, another SNP (Gm19_41366844) correlated identified through same models. Genes within 100 Kb interval upstream downstream loci were scanned analyzed for their functional annotation enrichment, one gene related to synthesis (Glyma.13G035600) (Glyma.19G147400) screened. The expressions candidate genes verified qRT-PCR, verification results, it hypothesized that Glyma.13G035600 Glyma.19G147400 positively regulate accumulation, respectively. above study lays foundation further validating functions, analyzing regulatory mechanisms accumulation soybean.

Язык: Английский

Innate immunity of vascular smooth muscle cells contributes to two-wave inflammation in atherosclerosis, twin-peak inflammation in aortic aneurysms and trans-differentiation potential into 25 cell types DOI Creative Commons

Qiaoxi Yang,

Fatma Saaoud,

Yifan Lu

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 14

Опубликована: Янв. 24, 2024

Introduction Vascular smooth muscle cells (VSMCs) are the predominant cell type in medial layer of aorta, which plays a critical role aortic diseases. Innate immunity is main driving force for cardiovascular Methods To determine roles innate VSMC and pathologies, we performed transcriptome analyses on aortas from ApoE –/– angiotensin II (Ang II)-induced aneurysm (AAA) time course, atherosclerosis as well VSMCs stimulated with danger-associated molecular patterns (DAMPs). Results We made significant findings: 1) 95% 45% upregulated immune pathways (UIIPs, based data 1226 genes) Ang II-induced AAA at 7 days were different that 14 28 days, respectively; showed twin peaks UIIPs major peak minor days; 2) all 6 weeks 32 78 (two waves); 3) additional 12 lists immune-related genes 1325 cytokine chemokine genes, 2022 plasma membrane protein 373 clusters differentiation (CD) marker 280 nuclear 1425 nucleoli 6750 nucleoplasm 1496 transcription factors (TFs) including 15 pioneer TFs, 164 histone modification enzymes, 102 oxidative death 68 necrotic 47 efferocytosis confirmed two-wave inflammation twin-peak AAA; 4) DAMPs-stimulated judged by upregulation lists; 5) increased trans-differentiation potential upregulating not only some 82 markers VSMC-plastic types, fibroblast, osteogenic, myofibroblast, macrophage, adipocyte, foam cell, mesenchymal but also 18 new types (out 79 human 8065 markers); 6) analysis gene deficient transcriptomes indicated antioxidant factor NRF2 suppresses, however, other five inflammatory master regulators, AHR, NF-KB, NOX (ROS enzyme), PERK, SET7 promote twelve atherosclerosis, AAA, DAMP-stimulated VSMCs; 7) both trained tolerance-promoting metabolite itaconate contributed to cytokines AAA. Discussion Our findings have provided novel insights responses stresses development immunology therapeutic targets treating those cerebrovascular

Язык: Английский

Процитировано

17

Biological transformation of medicine and food homology hawthorn with Monascus ruber to enhance lipid-lowering function DOI Creative Commons
Xue Dong,

Yongchao Cai,

Hui Liao

и другие.

Food Bioscience, Год журнала: 2024, Номер 58, С. 103825 - 103825

Опубликована: Март 1, 2024

Язык: Английский

Процитировано

4

A new paradigm in intracellular immunology: Mitochondria emerging as leading immune organelles DOI Creative Commons
Keman Xu,

Fatma Saaoud,

Ying Shao

и другие.

Redox Biology, Год журнала: 2024, Номер 76, С. 103331 - 103331

Опубликована: Авг. 29, 2024

Mitochondria, traditionally recognized as cellular 'powerhouses' due to their pivotal role in energy production, have emerged multifunctional organelles at the intersection of bioenergetics, metabolic signaling, and immunity. However, understanding exact contributions immunity inflammation is still developing. This review first introduces innovative concept intracellular immunity, emphasizing how mitochondria serve critical immune signaling hubs. They are instrumental recognizing responding pathogen danger signals, modulating responses. We also propose leading organelles, drawing parallels with broader system functions antigen presentation, regulation, response. Our comprehensive explores mitochondrial pathways, therapeutic potential managing chronic diseases, discusses cutting-edge methodologies for research. Targeting a broad readership both experts newcomers field, this sets forth new directions that could transform our integrated organelles.

Язык: Английский

Процитировано

4

4-tert-Butylphenol impairs the liver by inducing excess liver lipid accumulation via disrupting the lipid metabolism pathway in zebrafish DOI
Hui‐Yun Wang, Juan Liu,

Shuting Qiang

и другие.

Environmental Pollution, Год журнала: 2024, Номер 356, С. 124385 - 124385

Опубликована: Июнь 17, 2024

Язык: Английский

Процитировано

3

Alzheimer's disease as an auto-innate immune pathology with potential cell trans-differentiation and enhanced trained immunity in 3xTg-AD mouse model DOI

Fatma Saaoud,

Lu Liu,

Keman Xu

и другие.

Journal of Alzheimer s Disease, Год журнала: 2025, Номер unknown

Опубликована: Апрель 15, 2025

Background Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory impairment. Neuroinflammatory processes, mediated glial and immune cells, contribute to neuronal damage. Emerging evidence implicates innate mechanisms, including trained immunity cell trans-differentiation, in AD pathogenesis, though their roles remain unclear. Objective To investigate transcriptomic changes the 3xTg-AD mouse model, focusing on trans-differentiation mechanisms. Methods RNA-sequencing was performed brain tissue (cortex plus hippocampus) from 11-month-old female wild-type mice (n = 3/group). Differentially expressed genes (fold change > 1.5, p < 0.05) were identified followed bioinformatics knowledge-based profiling. Public datasets also analyzed. Results exhibited 316 upregulated 412 downregulated genes. Downregulated included those for blood-brain barrier protein, while related cerebrospinal fluid. Increased expression of proinflammatory markers, as well differentiation, proliferation, activation, adhesion. Upregulation associated with migration suggests potential role inflammation cellular plasticity. Additionally, involved inflammasome pathways, immunometabolism, upregulated. Mechanistically, these modulated knockdown promoter SET-7, overexpression inhibitor IL-37, knockout IL-1 receptor, caspase-1, pattern recognition receptor CD36. Conclusions The finding underscore AD, revealing mechanistic framework which danger-associated molecular patterns drive responses, plasticity offering therapeutic targets neuroinflammation reprograming.

Язык: Английский

Процитировано

0

Cardiovascular Disease Risk Factors, Immune Checkpoints and Tregs DOI
Ying Shao,

Fatma Saaoud,

Keman Xu

и другие.

Advances in biochemistry in health and disease, Год журнала: 2024, Номер unknown, С. 51 - 93

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

3

Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell Immunosuppression DOI Creative Commons
Ying Shao,

William Y. Yang,

Gayani Nanayakkara

и другие.

International Journal of Drug Discovery and Pharmacology, Год журнала: 2024, Номер unknown, С. 100022 - 100022

Опубликована: Ноя. 26, 2024

Although previous reviews explored the roles of selected immune checkpoints (ICPs) in cardiovascular diseases (CVD) and cerebrovascular from various perspectives, many related aspects have yet to be thoroughly reviewed analyzed. Our comprehensive review addresses this gap by discussing cellular functions ICPs, focusing on tissue-specific microenvironment-localized transcriptomic posttranslational regulation ICP expressions, as well their functional interactions with metabolic reprogramming. We also analyze how 14 pairs including CTLA-4/CD86-CD80, PD1-PDL-1, TIGIT-CD155, regulate CVD pathogenesis. Additionally, covers ICPs modulating CD4+Foxp3+ regulatory T cells (Tregs), cells, innate CVDs diseases. Furthermore, we outline seven immunological principles guide development new ICP-based therapies for CVDs. This timely thorough analysis recent advancements challenges provide insights into role CVDs, Tregs, will support novel therapeutics strategies these

Язык: Английский

Процитировано

2

The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment DOI Creative Commons
Mohammad Alwahsh,

Rahaf Alejel,

Aya Hasan

и другие.

Metabolites, Год журнала: 2024, Номер 14(8), С. 438 - 438

Опубликована: Авг. 6, 2024

Hyperlipidemia is a lipid metabolism disorder that refers to increased levels of total triglycerides (TGs), cholesterol (TC), and low-density lipoprotein-cholesterol (LDL-C) decreased high-density (HDL-C). It major public health issue with prevalence incidence worldwide. The ability identify individuals at risk this before symptoms manifest will facilitate timely intervention management avert potential complications. This can be achieved by employing metabolomics as an early detection method for the diagnostic biomarkers hyperlipidemia. Metabolomics analytical approach used detect quantify metabolites. provides explain metabolic processes involved in development progression certain diseases. In recent years, interest use disease has increased, several have been discovered, such docosahexaenoic acid, glycocholic citric betaine, carnitine. review discusses primary alterations context Furthermore, we provide overview studies on application assessment efficacy traditional herbal products common lipid-lowering medications.

Язык: Английский

Процитировано

0

Perspective: Pathological transdifferentiation—a novel therapeutic target for cardiovascular diseases and chronic inflammation DOI Creative Commons

William Y. Yang,

Melissa Mahgoub,

Fatma Saaoud

и другие.

Frontiers in Cardiovascular Medicine, Год журнала: 2024, Номер 11

Опубликована: Ноя. 26, 2024

Pathological transdifferentiation, where differentiated cells aberrantly transform into other cell types that exacerbate disease rather than promote healing, represents a novel and significant concept. This perspective discusses its role potential targeting in cardiovascular diseases chronic inflammation. Current therapies mainly focus on mitigating early inflammatory response through proinflammatory cytokines pathways targeting, including corticosteroids, TNF-α inhibitors, IL-1β monoclonal antibodies blockers, IL-6 nonsteroidal anti-inflammatory drugs (NSAIDs), along with modulating innate immune memory (trained immunity). However, these approaches often fail to address long-term tissue damage functional regeneration. For instance, fibroblasts can transdifferentiate myofibroblasts cardiac fibrosis, endothelial may undergo mesenchymal transition (EndMT) vascular remodeling, resulting fibrosis impaired function. Targeting pathological transdifferentiation promising therapeutic avenue by focusing key signaling drive aberrant cellular phenotypic transcriptomic transitions. approach seeks inhibit or modulate plasticity effective regeneration prevent fibrosis. Such strategies have the inflammation, death, damage, providing more comprehensive sustainable treatment solution. Future research should understanding mechanisms behind identifying relevant biomarkers master regulators, developing preclinical clinical trials. Integrating new existing treatments could enhance efficacy improve patient outcomes. Highlighting as target paradigms, leading better management recovery of tissues

Язык: Английский

Процитировано

0

Editorial: Debates in cardiovascular pharmacology and drug discovery: 2022 DOI Creative Commons
Keman Xu,

Fatma Saaoud,

Ying Shao

и другие.

Frontiers in Cardiovascular Medicine, Год журнала: 2023, Номер 10

Опубликована: Окт. 18, 2023

EDITORIAL article Front. Cardiovasc. Med., 18 October 2023Sec. Cardiovascular Pharmacology and Drug Discovery Volume 10 - 2023 | https://doi.org/10.3389/fcvm.2023.1304680

Язык: Английский

Процитировано

0